SEC Form 4 · accession 0001140361-16-063018
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Emerson
Director
Period of report
Apr 29, 2016
Accepted (ET)
May 3, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 29, 2016 | A | 2,145 | — | A | 9,153 | D | |
| Common Stock | May 1, 2016 | F | 718 | $34.95 | D | 8,435 | D | |
| Common Stock | holding | — | — | — | 7,008 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $10.98 | holding | — | — | — | — | May 12, 2020 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $11.72 | holding | — | — | — | — | Apr 22, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $11.63 | holding | — | — | — | — | May 4, 2022 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Represents restricted stock award that shall become 100% fully vested on April 29, 2017, subject to continuation of service as a Director of the Company.
- F2100% fully vested.